Efficacy and durability of cognitive behavior therapy in managing hallucination in patients with schizophrenia

Priyanka Shukla; Debasish Padhi; KS Sengar; Abha Singh; Suprakash Chaudhury

doi:10.4103/ipj.ipj_94_20

Users Online: 843

ORIGINAL ARTICLE

Year : 2021 | Volume : 30 | Issue : 2 | Page : 255-264

Efficacy and durability of cognitive behavior therapy in managing hallucination in patients with schizophrenia

Priyanka Shukla¹, Debasish Padhi², KS Sengar³, Abha Singh⁴, Suprakash Chaudhury⁵
¹ Department of Psychology, CSJM University, Ranchi, Jharkhand, India
² Department of Psychiatry, Rama Medical College, Ranchi, Jharkhand, India
³ Department of Clinical Psychology, RINPAS, Ranchi, Jharkhand, India
⁴ Department of Psychology, P.P.N. College, CSJM University, Kanpur, Uttar Pradesh, India
⁵ Department of Psychiatry, Dr D Y Patil Medical College, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India

Correspondence Address:
Dr. Suprakash Chaudhury
Department of Psychiatry, Dr D Y Patil Medical College, Dr D Y Patil Vidyapeeth, Pimpri, Pune - 411 018, Maharashtra
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/ipj.ipj_94_20

Background: The cognitive behavior therapy (CBT) approach to psychosis is a relatively recent development and focuses directly on the core psychotic symptoms of hallucinations and delusions. Aim: The aim of this study is to assess the efficacy of cognitive behavior therapy in managing hallucination in patients with schizophrenia and to evaluate the generalizability and durability of the therapeutic gains. Materials and Methods: In this confirmatory pre–post assessment study, based on the purposive sampling technique, a sample consisting of 40 (20 for experimental and the other 20 for control group) patients having schizophrenia with core symptoms of hallucination and delusions under treatment as usual were selected and matched on the sociodemographic and clinical variables. For the clinical variables, the Psychotic Symptom Rating Scale and Scale for the Assessment of Positive Symptoms were used. After baseline assessment, the cognitive behavioral program was tailored on the experimental group and patients of both the group were reassessed after the completion of treatment. Follow-up data to see the durability of program were taken from all the patients of experimental and control groups. Results: Cognitive behavior therapy was found to be effective for the treatment of auditory hallucination in schizophrenia. The therapeutic gains in all study variables were found to be maintained or further improving at follow-up which proves that cognitive behavior therapy is durable. Conclusion: Cognitive behavior therapy in conjunction with pharmacotherapy was found to be more effective in improving clinical symptoms of schizophrenia and global functioning compared to pharmacotherapy alone.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	1658

Printed	49

Emailed	0

PDF Downloaded	191

Comments	[Add]